Our experience represents a significant advantage to clients who are newer entrants to the life sciences sector.
The development of cannabinoid pharmaceuticals and wellness applications has gained genuine interest in the life sciences sector, led to significant R&D investment and contributed to the successful launch of companies promoting cannabis and hemp CBD products, despite FDA’s prohibition on CBD-infused food and beverages.
The continued regulatory uncertainty surrounding cannabis and hemp CBD-infused products coincides with a notable rise in the number of commercial disputes, product liability claims and consumer class actions related to these products. California courts have been particularly busy litigating claims of false advertising, deceptive business practices, fraudulent inducement, racketeering and related counts against CBD manufacturers and retailers.
We know the Life Sciences Industry. For more than 25 years, we have represented life science companies in national and state mass tort product liability litigation, class actions, and state attorney general claims brought under state consumer protection statutes. In addition to defending against these claims, we have provided counseling and prelitigation assessments, including labeling reviews.
Our experience represents a significant advantage to clients who are newer entrants to the life sciences sector. We also have an extensive network of working relationships with other counsel in California and across the country, as well as a group of highly talented regulatory and scientific experts.